Diagnos Inc (ADK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Diagnos Inc (ADK) has a cash flow conversion efficiency ratio of 0.539x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-828.10K ≈ $-599.04K USD) by net assets (CA$-1.54 Million ≈ $-1.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Diagnos Inc - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Diagnos Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ADK liabilities breakdown for a breakdown of total debt and financial obligations.
Diagnos Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Diagnos Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Akari Therapeutics PLC
NASDAQ:AKTX
|
-0.093x |
|
Otto Energy Ltd
AU:OEL
|
0.142x |
|
Kadestone Capital Corp
V:KDSX
|
-0.401x |
|
Fondia Oyj
HE:FONDIA
|
-0.113x |
|
Intersport Polska S.A.
WAR:IPO
|
0.401x |
|
Lancashire Holdings Ltd
LSE:LRE
|
0.018x |
|
OXE Marine AB
ST:OXE
|
-0.326x |
|
PeterLabs Holdings Bhd
KLSE:0171
|
0.107x |
Annual Cash Flow Conversion Efficiency for Diagnos Inc (2002–2025)
The table below shows the annual cash flow conversion efficiency of Diagnos Inc from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see ADK company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | CA$233.11K ≈ $168.63K |
CA$-3.64 Million ≈ $-2.63 Million |
-15.604x | -2076.03% |
| 2024-03-31 | CA$-3.05 Million ≈ $-2.21 Million |
CA$-2.41 Million ≈ $-1.74 Million |
0.790x | -18.33% |
| 2023-03-31 | CA$-1.95 Million ≈ $-1.41 Million |
CA$-1.88 Million ≈ $-1.36 Million |
0.967x | -94.61% |
| 2022-03-31 | CA$-113.51K ≈ $-82.11K |
CA$-2.04 Million ≈ $-1.47 Million |
17.954x | +1598.12% |
| 2021-03-31 | CA$1.13 Million ≈ $818.98K |
CA$-1.36 Million ≈ $-981.49K |
-1.198x | +17.44% |
| 2020-03-31 | CA$1.82 Million ≈ $1.32 Million |
CA$-2.64 Million ≈ $-1.91 Million |
-1.452x | -418.05% |
| 2019-03-31 | CA$-5.08 Million ≈ $-3.68 Million |
CA$-2.32 Million ≈ $-1.68 Million |
0.456x | -26.02% |
| 2018-03-31 | CA$-3.64 Million ≈ $-2.63 Million |
CA$-2.24 Million ≈ $-1.62 Million |
0.617x | +92.48% |
| 2017-03-31 | CA$-5.58 Million ≈ $-4.03 Million |
CA$-1.79 Million ≈ $-1.29 Million |
0.321x | -54.80% |
| 2016-03-31 | CA$-3.15 Million ≈ $-2.28 Million |
CA$-2.23 Million ≈ $-1.62 Million |
0.709x | -94.44% |
| 2015-03-31 | CA$-224.85K ≈ $-162.65K |
CA$-2.87 Million ≈ $-2.07 Million |
12.748x | +464.40% |
| 2014-03-31 | CA$346.95K ≈ $250.98K |
CA$-1.21 Million ≈ $-878.01K |
-3.498x | -204.12% |
| 2013-03-31 | CA$1.75 Million ≈ $1.26 Million |
CA$-2.01 Million ≈ $-1.45 Million |
-1.150x | -41.39% |
| 2012-03-31 | CA$2.34 Million ≈ $1.70 Million |
CA$-1.91 Million ≈ $-1.38 Million |
-0.814x | +31.73% |
| 2011-03-31 | CA$1.18 Million ≈ $855.17K |
CA$-1.41 Million ≈ $-1.02 Million |
-1.192x | -56.73% |
| 2010-03-31 | CA$1.98 Million ≈ $1.43 Million |
CA$-1.51 Million ≈ $-1.09 Million |
-0.760x | -4.87% |
| 2009-03-31 | CA$2.41 Million ≈ $1.74 Million |
CA$-1.75 Million ≈ $-1.26 Million |
-0.725x | -557420.15% |
| 2008-03-31 | CA$4.21 Million ≈ $3.04 Million |
CA$-547.00 ≈ $-395.69 |
0.000x | +99.98% |
| 2007-03-31 | CA$1.42 Million ≈ $1.03 Million |
CA$-876.30K ≈ $-633.90K |
-0.616x | +60.42% |
| 2006-03-31 | CA$793.68K ≈ $574.14K |
CA$-1.24 Million ≈ $-894.18K |
-1.557x | +86.16% |
| 2005-03-31 | CA$161.61K ≈ $116.91K |
CA$-1.82 Million ≈ $-1.32 Million |
-11.252x | -1503.98% |
| 2004-03-31 | CA$-128.75K ≈ $-93.14K |
CA$-103.19K ≈ $-74.64K |
0.801x | -73.66% |
| 2003-03-31 | CA$-264.64K ≈ $-191.44K |
CA$-805.06K ≈ $-582.37K |
3.042x | -56.40% |
| 2002-03-31 | CA$-325.75K ≈ $-235.64K |
CA$-2.27 Million ≈ $-1.64 Million |
6.978x | -- |
About Diagnos Inc
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and patho… Read more